Researchers conducted a retrospective study published in July 2025 issue of Journal of Clinical Oncology to evaluate risk-adaptive, surgery– and radiotherapy-free management following neoadjuvant ...

A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited ...

Gilead Sciences ( ($GILD) ) has risen by 7.31%. Read on to learn why. Gilead Sciences has seen a notable increase in its ...